≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Congenital malformations of posterior segment of eye

EFO Endpoint Browser PheWeb

Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q14
  • Cause of death: ICD-10 — Q14

2 out of 7 registries used, show all original rules.

189

4. Check minimum number of events

None

189

5. Include endpoints

189

6. Filter based on genotype QC (FinnGen only)

178

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q1
Name in latin
Malformationes congenitae segmenti posterioris oculi

Similar endpoints

↥

List of similar endpoints to Congenital malformations of posterior segment of eye based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2267 918 1344
Only index persons 1896 773 1123
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.04
Only index persons 0.04 0.03 0.04
Median age at first event (years)
Whole population 18.62 21.64 16.46
Only index persons 25.83 31.39 22.00

-FinnGen-

Key figures

All Female Male
Number of individuals 178 87 91
Unadjusted period prevalence (%) 0.04 0.03 0.04
Median age at first event (years) 46.92 50.76 43.24

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
189
Matched controls
1890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q14.10
ICD-10 Finland
Congenital retinoschis
+∞
85.0
75
*
Q14.2
ICD-10 Finland
Congenital malformation of optic disc
+∞
52.6
48
*
Q14.8
ICD-10 Finland
Other congenital malformations of posterior segment of eye
+∞
36.7
34
*
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
71.5
22.5
25
*
Z3229
NOMESCO Finland
Other healthcare associate professional
6.2
22.4
45
91
Q14.18
ICD-10 Finland
Congenital malformation of retina
+∞
22.3
21
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.7
19.6
42
90
XCK10
NOMESCO Finland
Photography of fundus of eye
5.2
16.0
37
84
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.5
15.1
43
116
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.1
13.0
24
44
Q14.0
ICD-10 Finland
Congenital malformation of vitreous humour
+∞
12.6
12
*
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
127.5
11.6
12
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
10.6
57
232
XCD10
NOMESCO Finland
Electrophysiological examination of eye
11.6
10.5
19
18
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
21.5
10.0
14
7
Z31.5
ICD-10 Finland
Genetic counselling
4.5
9.9
26
65
CKC12
NOMESCO Finland
Photocoagulation of retina
5.3
9.5
20
41
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
8.9
34
111
H53.0
ICD-10 Finland
Amblyopia ex anopsia
15.0
8.8
14
10
Q13.0
ICD-10 Finland
Coloboma of iris
+∞
8.4
8
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.6
8.4
30
94
Z2446
NOMESCO Finland
Social worker
3.5
8.1
30
96
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
7.7
26
78
DFF00
NOMESCO Finland
Pure tone audiometry
3.5
7.7
29
94
H52.1
ICD-10 Finland
Myopia
6.7
7.5
18
29
Q14.9
ICD-10 Finland
Congenital malformation of posterior segment of eye, unspecified
+∞
7.3
7
*
XCK00
NOMESCO Finland
Perimetry
4.5
7.2
18
43
UDC00
NOMESCO Finland
Ear microscopy
3.4
6.4
24
77
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.4
6.2
16
39
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
6.0
39
171

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
130
1002
1.95
4.33
5.2
4.3
—
—
—
0
0
20
77
2.79
3.95
11.7
9.0
0.65
0.65
%
0.01
20
77
20
80
2.68
3.69
11.7
8.7
0.92
1.28
%
1.04
20
80
138
1116
1.88
3.61
7.4
7.7
84.06
91.62
u/l
0.96
133
1059
32
170
2.06
3.15
11.8
9.9
5.34
4.91
kpa
0.49
32
165
32
171
2.05
3.10
27.8
9.9
—
—
—
0
0
83
598
1.69
3.09
5.6
6.0
35.62
35.74
g/l
0.07
77
578
96
722
1.67
3.02
12.5
10.1
1.22
1.22
mmol/l
0.33
86
629
5
5
10.22
2.99
6.6
2.8
—
—
—
0
0
28
144
2.11
2.99
12.4
11.5
9.44
8.16
mmol/l
0.40
28
139
36
206
1.92
2.88
3.4
2.7
2.42
2.38
g/l
0.22
36
192
33
184
1.96
2.84
12.7
10.3
0.91
1.56
mmol/l
0.46
28
152
23
112
2.20
2.81
9.0
7.7
—
—
—
0
0
11
34
3.37
2.77
17.5
15.0
72.36
66.95
%
0.45
11
34
12
40
3.13
2.75
16.2
14.7
—
—
—
0
0
57
388
1.67
2.55
4.3
3.8
7.53
57.00
mg/mmol
0.57
40
249
53
364
1.63
2.26
4.7
4.6
—
—
—
0
0
22
116
2.01
2.22
1.6
1.5
—
—
—
0
0
8
24
3.43
2.20
2.0
4.8
30.64
35.62
%
—
8
24
80
609
1.54
2.20
9.1
11.5
1.27
1.21
inr
0.25
25
179
132
1124
1.58
2.16
4.4
4.2
12.78
11.05
mm/h
0.52
125
1047
37
234
1.72
2.14
13.4
9.1
1.15
1.19
mmol/l
0.26
37
220
40
259
1.69
2.13
3.9
3.6
3.06
2.22
e6/l
0.19
28
139
103
833
1.52
2.12
7.3
7.8
1.94
2.13
e9/l
0.49
94
742
170
1552
1.95
2.06
15.2
14.0
19.72
21.89
mg/l
0.49
142
1181
30
181
1.78
2.04
1.6
1.6
—
—
—
0
0
94
752
1.50
2.00
6.1
7.5
12.64
11.30
umol/l
0.24
89
723
184
1751
2.92
1.98
26.4
20.3
39.36
40.27
%
1.08
173
1665
108
892
1.49
1.95
11.8
6.2
6.65
6.62
mmol/l
0.05
100
829
100
815
1.48
1.92
7.3
7.7
0.04
0.04
e9/l
0.05
90
697
111
924
1.49
1.91
9.9
11.4
4.30
3.95
e9/l
0.73
102
796
100
816
1.48
1.90
7.2
7.6
0.56
0.58
e9/l
0.31
89
700
60
441
1.53
1.89
4.4
3.6
6.81
8.18
mmol/l
1.91
54
386
93
749
1.48
1.88
8.2
8.7
—
—
—
0
0
5
12
4.25
1.83
1.2
2.4
2154.60
767.33
u/ml
—
5
12
51
366
1.54
1.78
4.0
3.1
40.90
89.18
mg/l
1.15
33
241
24
142
1.79
1.75
9.8
8.0
—
7.41
—
0
15
62
466
1.49
1.75
3.2
3.5
2.37
2.36
mmol/l
0.28
55
419
36
239
1.63
1.74
3.9
3.2
29.98
30.35
s
0.18
36
229
67
512
1.48
1.74
1.9
1.8
99.90
95.38
pmol/l
0.34
38
267
24
143
1.78
1.71
9.8
8.1
5.35
4.98
kpa
1.11
24
135
48
343
1.54
1.71
2.4
2.6
2.86
2.89
mg/l
0.04
42
303
26
159
1.74
1.70
33.1
13.8
25.25
25.08
mmol/l
0.12
26
159
30
192
1.67
1.67
2.1
2.1
—
—
—
0
0
53
389
1.50
1.66
3.3
3.0
—
—
—
0
0
100
830
1.43
1.66
7.9
8.1
0.14
0.20
e9/l
4.31
91
735
20
114
1.84
1.64
5.6
4.3
—
—
—
0
0
5
14
3.64
1.62
2.8
1.4
—
—
—
0
0
6
20
3.06
1.59
14.7
23.8
11.70
12.68
%
—
6
20
6
20
3.06
1.59
1.2
3.6
1.50
1.60
umol/l
—
6
20
33
220
1.61
1.57
1.6
1.6
812.51
1250.61
nmol/l
3.06
27
174
8
33
2.49
1.55
2.3
1.7
—
—
—
0
0
87
712
1.41
1.53
4.1
3.8
0.00
0.01
estimate
0.50
13
145
57
433
1.45
1.50
5.0
7.8
—
—
—
0
0
23
142
1.71
1.46
1.7
2.1
11.16
12.74
nmol/l
0.48
23
134
55
417
1.45
1.46
6.1
4.6
7.41
7.40
ph
—
8
82
5
16
3.18
1.44
1.2
1.1
—
—
—
0
0
5
16
3.18
1.44
1.0
1.2
—
—
—
0
0
86
708
1.39
1.44
6.7
5.4
0.00
0.00
estimate
-0.00
12
141
42
303
1.50
1.42
4.3
3.3
583.76
544.73
mosm/kgh2o
0.37
37
255
12
60
2.07
1.41
46.1
18.8
—
—
—
0
0
57
438
1.43
1.40
4.4
3.5
1.47
0.38
e6/l
0.72
46
325
12
218
0.52
1.39
1.0
1.6
—
—
—
0
0
5
17
2.99
1.36
5.6
2.8
—
—
—
0
0
61
477
1.41
1.36
2.7
2.7
—
—
—
0
0
17
98
1.81
1.36
1.4
1.6
—
—
—
0
0
87
723
1.38
1.35
4.1
3.9
0.00
0.02
estimate
0.50
12
131
6
24
2.55
1.31
1.5
1.3
—
—
—
0
0
5
18
2.82
1.29
3.2
2.8
4.00
4.04
mmol/l
—
5
18
5
18
2.82
1.29
3.2
2.8
105.60
106.17
mmol/l
—
5
18
5
18
2.82
1.29
3.2
2.8
—
—
—
0
0
17
101
1.75
1.24
9.8
8.6
10.41
9.39
kpa
0.48
17
95
47
357
1.42
1.23
4.6
4.0
—
—
—
0
0
60
479
1.37
1.17
4.4
3.7
62.70
173.79
e6/l
0.36
50
363
41
308
1.42
1.13
2.8
2.5
0.83
1.45
mg/l
1.07
31
238
171
1617
1.60
1.10
13.8
11.7
—
—
—
0
0
8
149
0.52
1.09
1.5
1.5
—
—
—
0
0
40
303
1.41
1.06
1.8
1.5
19.88
20.97
nmol/l
0.15
35
257
31
225
1.45
1.03
1.5
1.2
25.55
6.89
u/ml
0.51
13
85
9
49
1.88
1.00
1.2
1.2
—
—
—
0
0
129
1172
1.32
0.97
3.6
3.7
14.83
14.67
pmol/l
0.25
116
1079
26
185
1.47
0.96
1.3
1.2
—
—
—
0
0
6
27
2.26
0.94
6.2
5.5
1.55
1.57
mmol/l
—
6
27
151
1407
1.36
0.93
4.6
4.3
1.90
2.76
mu/l
0.51
142
1300
85
739
1.27
0.87
10.2
11.8
0.00
0.00
e9/l
0.36
72
584
148
1382
1.33
0.84
4.1
3.8
1.18
1.25
mmol/l
0.78
137
1280
12
74
1.66
0.80
1.9
2.0
12.30
18.69
iu/l
—
7
61
26
342
0.72
0.78
2.5
1.8
—
—
—
0
0
9
53
1.73
0.76
4.1
2.2
899.56
242.26
ug/l
—
9
47
9
56
1.64
0.73
1.8
1.6
—
—
—
0
0
106
960
1.24
0.72
3.1
3.5
—
—
—
0
0
5
26
1.95
0.71
5.0
5.7
7.72
7.32
mmol/l
—
5
26
68
589
1.24
0.69
3.8
3.4
5.90
5.95
ph
—
5
56
7
42
1.69
0.69
1.1
3.2
—
—
—
0
0
43
353
1.28
0.68
3.5
3.6
—
—
—
0
0
30
236
1.32
0.65
1.3
1.2
21.04
34.63
iu/ml
0.63
11
78
54
459
1.25
0.65
1.6
1.5
—
—
—
0
0
64
555
1.23
0.64
5.4
4.4
18.63
58.37
e6/l
1.15
48
381
51
433
1.24
0.62
4.6
3.3
—
—
—
0
0
5
30
1.68
0.62
1.4
5.2
—
—
—
0
0
5
30
1.68
0.62
1.4
1.1
—
—
—
0
0
19
140
1.40
0.61
2.6
4.2
63.83
68.36
e9/l
0.35
12
108
6
35
1.74
0.58
1.8
5.0
—
—
—
0
0
8
54
1.50
0.58
1.1
1.1
—
—
—
0
0
6
36
1.69
0.57
11.5
5.2
—
—
—
0
0
11
74
1.52
0.54
2.3
2.0
4.04
6.07
u/l
—
6
56
43
364
1.23
0.54
3.2
4.2
0.00
0.00
estimate
-0.00
12
133
9
64
1.43
0.52
1.1
1.1
—
—
—
0
0
16
119
1.38
0.50
2.8
6.3
0.00
0.20
%
—
6
44
57
501
1.20
0.49
5.1
3.6
133.50
37.03
ng/l
0.48
44
330
20
155
1.32
0.49
1.3
1.3
—
—
—
0
0
7
46
1.54
0.49
1.7
3.6
397.43
465.26
mg/l
—
7
46
60
531
1.19
0.48
1.7
2.0
—
—
—
0
0
15
111
1.38
0.48
2.4
6.0
0.43
0.46
%
—
7
41
28
229
1.26
0.47
2.3
3.0
2.44
2.45
mmol/l
0.25
23
202
47
537
0.83
0.47
2.8
2.8
—
—
—
0
0
17
130
1.34
0.46
2.7
5.9
1.00
0.95
%
—
7
55
149
1427
1.21
0.45
4.6
4.1
1.45
1.47
mmol/l
0.26
138
1326
10
69
1.47
0.45
7.5
3.9
—
—
—
0
0
13
173
0.73
0.44
1.2
1.2
—
—
—
0
0
20
158
1.30
0.44
1.1
1.3
—
—
—
0
0
5
31
1.63
0.43
1.4
1.1
—
—
—
0
0
49
431
1.18
0.42
4.2
4.8
2.41
2.91
ug/l
0.23
44
382
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
5
34
1.48
0.40
1.0
4.2
—
—
—
0
0
5
35
1.44
0.39
2.0
1.2
—
—
—
0
0
21
170
1.26
0.39
1.3
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
30
254
1.22
0.38
4.5
3.5
235.52
219.86
ng/l
0.03
23
188
149
1435
1.18
0.38
4.6
4.2
4.54
4.66
mmol/l
0.86
138
1348
11
82
1.36
0.35
3.9
2.3
—
—
—
0
0
35
399
0.85
0.34
1.7
1.8
1.21
1.40
mmol/l
0.78
30
349
37
324
1.18
0.34
3.1
2.7
5.93
5.19
e6/l
0.13
32
286
6
45
1.34
0.34
2.5
2.7
—
—
—
0
0
146
1409
1.16
0.33
19.8
17.2
333.34
333.87
g/l
0.28
146
1403
138
1328
1.15
0.32
5.6
5.3
39.06
39.61
mmol/mol
0.31
130
1252
24
204
1.20
0.30
1.2
1.4
493.33
422.11
titre
—
6
38
8
62
1.30
0.28
1.0
1.1
—
—
—
0
0
13
104
1.27
0.27
4.5
2.1
—
—
—
0
0
5
74
0.67
0.26
5.0
10.4
—
—
—
0
0
29
257
1.15
0.24
3.7
3.0
0.67
0.78
ug/l
0.34
17
165
37
407
0.89
0.23
1.6
1.6
1.81
2.17
g/l
0.52
19
232
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
4.8
—
44.20
—
0
10
0
10
0.00
0.21
0.0
1.5
—
1.42
—
0
10
0
12
0.00
0.21
0.0
1.8
—
1.14
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
50
1.21
0.20
3.5
1.7
—
—
—
0
0
14
164
0.84
0.19
1.3
1.5
—
—
—
0
0
149
1458
1.10
0.18
5.2
4.6
2.65
2.78
mmol/l
1.17
138
1358
7
61
1.15
0.17
1.1
1.8
—
—
—
0
0
12
101
1.20
0.17
2.6
3.6
—
—
—
0
0
9
80
1.13
0.15
3.0
1.6
—
—
—
0
0
14
160
0.87
0.14
1.3
1.8
—
—
—
0
0
42
395
1.08
0.13
4.7
3.5
—
—
—
0
0
26
279
0.92
0.10
2.2
1.7
—
—
—
0
0
16
176
0.90
0.10
1.4
1.7
—
—
—
0
0
19
206
0.91
0.09
2.4
1.5
—
—
—
0
0
11
97
1.14
0.09
1.3
1.4
—
—
—
0
0
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
6
58
1.04
0.08
3.2
3.7
5.00
201.47
u/ml
—
6
50
6
71
0.84
0.08
2.0
2.2
—
—
—
0
0
6
70
0.85
0.08
1.0
1.3
—
—
—
0
0
6
72
0.83
0.08
1.0
1.3
—
—
—
0
0
6
72
0.83
0.08
1.0
1.3
—
—
—
0
0
6
72
0.83
0.08
1.0
1.3
—
—
—
0
0
10
89
1.13
0.07
1.1
1.2
—
—
—
0
0
12
109
1.11
0.06
2.8
5.2
1.21
1.22
mmol/l
0.42
12
101
13
119
1.10
0.06
1.8
1.4
—
—
—
0
0
14
129
1.09
0.06
5.9
1.9
3.32
1.14
g/l
0.41
14
122
140
1391
1.02
0.02
5.0
4.1
5.72
5.83
mmol/l
0.70
132
1290
12
127
0.94
0.01
3.8
4.1
—
—
—
0
0
43
423
1.02
0.01
1.4
1.6
0.65
1.41
u/ml
—
8
100
37
371
1.00
0.00
3.8
3.4
361.38
6388.70
umol/l
1.49
37
332
16
155
1.04
0.00
2.5
3.5
0.20
0.21
g/l
0.27
16
146
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
6
69
0.87
0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
5
51
0.98
-0.00
1.4
2.0
0.14
7.01
ug/l
—
5
45
0
8
0.00
-0.00
0.0
9.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
17.6
—
8.93
—
0
7
0
7
0.00
-0.00
0.0
3.4
—
4.69
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
166.29
—
0
7
6
59
1.02
-0.00
9.5
5.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
1955.63
—
0
8
0
7
0.00
-0.00
0.0
1.1
—
1315.00
—
0
7
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
13.03
—
0
5
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
25.28
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
11.2
—
0.65
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE and mortality.

Females

Parameter HR [95% CI] p-value
Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE 1.133 [0.83, 1.54] 0.424
Birth year 0.996 [0.99, 1.01] 0.419

During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 832 females with Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE died.

Males

Parameter HR [95% CI] p-value
Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE 0.919 [0.7, 1.21] 0.544
Birth year 0.986 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 85 out of 1243 males with Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE.

N-year risk Females Males
1 0.1% 0.158%
5 0.631% 0.93%
10 1.739% 2.363%
15 3.15% 4.483%
20 5.696% 7.972%

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE – Congenital malformations of posterior segment of eye

GWS hits: 3

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data